Top

Published in:

Open Access 01-08-2016 | Gynecologic Oncology

Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue

Authors: Inge T. A. Peters, Carina G. J. M. Hilders, Cornelis F. M. Sier, Alexander L. Vahrmeijer, Vincent T. H. B. M. Smit, J. Baptist Trimbos, Peter J. K. Kuppen

Published in: Archives of Gynecology and Obstetrics | Issue 2/2016

Abstract

Purpose

The safety of ovarian tissue autotransplantation in oncology patients cannot be ensured, as current tumor-detection methods compromise the ovarian tissue viability. Although non-destructive methods (for instance near-infrared fluorescence imaging) can discriminate malignant from healthy tissues while leaving the examined tissues unaffected, they require specific cell-surface tumor markers. We determined which tumor markers are suitable targets for tumor-specific imaging to exclude the presence of breast cancer cells in ovarian tissue.

Methods

Immunohistochemistry was performed on formalin-fixed, paraffin-embedded specimens of ten ovaries from premenopausal patients. Additionally, we screened a tissue microarray containing tumor tissue cores from 24 breast cancer patients being eligible for ovarian tissue cryopreservation. The following cell-surface tumor markers were tested: E-cadherin, EMA (epithelial membrane antigen), Her2/neu (human epidermal growth factor receptor type 2), αvβ6 integrin, EpCAM (epithelial cell adhesion molecule), CEA (carcinoembryonic antigen), FR-α (folate receptor-alpha), and uPAR (urokinase-type plasminogen activator receptor). For each tumor, the percentage of positive breast tumor cells was measured.

Results

None of the ten ovaries were positive for any of the markers tested. However, all markers (except CEA and uPAR) were present on epithelial cells of inclusion cysts. E-cadherin was present in the majority of breast tumors: ≥90 % of tumor cells were positive for E-cadherin in 17 out of 24 tumors, and 100 % of tumor cells were positive in 5 out of 24 tumors.

Conclusions

Of the markers tested, E-cadherin is the most suitable marker for a tumor-specific probe in ovarian tissue. Methods are required to distinguish inclusion cysts from breast tumor cells.

Blumenfeld Z (2012) Chemotherapy and fertility. Best Pract Res Clin Obstet Gynaecol 26(3):379–390CrossRefPubMed

Loscalzo MJ (2007) The psychosocial context of cancer-related infertility. Cancer Treat Res 138:180–190CrossRefPubMed

Jeruss JS, Woodruff TK (2009) Preservation of fertility in patients with cancer. N Engl J Med 360:902–911CrossRefPubMedPubMedCentral

Rodriguez-Wallberg KA, Oktay K (2012) Recent advances in oocyte and ovarian tissue cryopreservation and transplantation. Best Pract Res Clin Obstet Gynaecol. 26(3):391–405CrossRefPubMedPubMedCentral

Von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B (2011) Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet 284:427–435CrossRef

Donnez J, Dolmans M-M, Pellicer A et al (2013) Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 99(6):1503–1513CrossRefPubMed

Stoop D, Cobo A, Silber S (2014) Fertility preservation for age-related fertility decline. Lancet 384(9950):1311–1319CrossRefPubMed

Bastings L, Beerendonk CCM, Westphal JR et al (2013) Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update, pp 1–24

Bastings L, Beerendonk CCM, Westphal JR, Braat DDM, Peek R (2013) Cryopreservation and autotransplantation of ovarian tissue in cancer patients: is it safe? J Adolesc Young Adult Oncol 2(1):31–34CrossRef

10.

Vahrmeijer AL, Hutteman M, Van Der Vorst JR, Van De Velde CJ, Frangioni JV (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 10(9):507–518CrossRefPubMedPubMedCentral

11.

Keereweer S, Kerrebijn JDF, Van Driel PBAA et al (2011) Optical image-guided surgery—where do we stand? Mol Imaging Biol 13(2):199–207CrossRefPubMed

12.

Te Velde EA, Veerman T, Subramaniam V, Ruers T (2010) The use of fluorescent dyes and probes in surgical oncology. Eur J Surg Oncol 36(1):6–15CrossRef

13.

Rosendahl M, Schmidt KT, Ernst E et al (2011) Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod Biomed Online 22(2):162–171CrossRefPubMed

14.

Dolmans M-M, Jadoul P, Gilliaux S et al (2013) A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet 30(3):305–314CrossRefPubMedPubMedCentral

15.

Oktay K, Oktem O (2010) Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. Fertil Steril 93(3):762–768CrossRefPubMed

16.

Hoekman EJ, Smit VT, Fleming TP, Louwe LA, Fleuren GJ, Hilders CG (2014) Searching for metastases in ovarian tissue before autotransplantation: a tailor-made approach. Fertil Steril 103(2):469–477CrossRefPubMed

17.

Perrotin F, Marret H, Bouquin R, Lansac J, Body G (2001) Incidence, diagnostic et pronostic des métastases ovariennes du cancer du sein. Gynécol Obstét Fertil 29:308–315CrossRefPubMed

18.

Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, Mcguire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182CrossRefPubMed

19.

Weigelt B, Peterse JL, van ‘t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5(8):591–602CrossRefPubMed

20.

Cowin P, Rowlands TM, Hatsell SJ (2005) Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17(5):499–508CrossRefPubMed

21.

Kuhajda FP, Offutt LE, Mendelsohn G (1983) The distribution of carcinoembryonic antigen in breast carcinoma. Diagnostic and prognostic implications. Cancer 52(7):1257–1264CrossRefPubMed

22.

Schnell U, Cirulli V, Giepmans BNG (2013) EpCAM: structure and function in health and disease. Biochim Biophys Acta 1828(8):1989–2001CrossRefPubMed

23.

Soysal SD, Muenst S, Barbie T et al (2013) EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer. Br J Cancer 108(7):1480–1487CrossRefPubMedPubMedCentral

24.

Rathinam R, Alahari SK (2010) Important role of integrins in the cancer biology. Cancer Metastasis Rev 29(1):223–237CrossRefPubMed

25.

Boonstra MC, Verspaget HW, Ganesh S et al (2011) Clinical applications of the urokinase receptor (uPAR) for cancer patients. Curr Pharm Des 17(19):1890–1910CrossRefPubMed

26.

Tang L, Han X (2013) The urokinase plasminogen activator system in breast cancer invasion and metastasis. Biomed Pharmacother 67(2):179–182CrossRefPubMed

27.

Tornos C, Soslow R, Chen S et al (2005) Expression of WT1, CA 125 and GCFFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 29:1482–1489CrossRefPubMed

28.

Luyckx V, Durant JF, Camboni A et al (2013) Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study. J Assist Reprod Genet 30(10):1289–1299CrossRefPubMedPubMedCentral

29.

Markert S, Lassmann S, Gabriel B et al (2008) Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue. Anticancer Res 28:3567–3572PubMed

30.

Sánchez-Serrano M, Novella-Maestre E, Roselló-Sastre E, Camarasa N, Teruel J, Pellicer A (2009) Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum Reprod 24(9):2238–2243CrossRefPubMed

31.

Rosendahl M, Timmermans Wielenga V, Nedergaard L et al (2011) Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertil Steril 95(6):2158–2161CrossRefPubMed

32.

Nederlands Netwerk Fertiliteitspreservatie (NNF; Dutch Network of Fertility Preservation) (2012) Landelijk protocol cryopreservatie en transplantatie van ovariumweefsel. http://nnf-info.nl. Updated September 2012

33.

Schaafsma BE, Mieog JSD, Hutteman M et al (2011) The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 104(3):323–332CrossRefPubMedPubMedCentral

34.

Hutteman M, Van Der Vorst JR, Mieog JSD et al (2011) Near-infrared fluorescence imaging in patients undergoing pancreaticoduodenectomy. Eur Surg Res 47(2):90–97CrossRefPubMedPubMedCentral

35.

Van Der Vorst JR, Schaafsma BE, Hutteman M et al (2013) Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer 119(18):3411–3418CrossRefPubMedPubMedCentral

36.

Scully OJ, Bay B-H, Yip G, Yu Y (2012) Breast cancer metastasis. Cancer Genomics Proteomics 9:311–320PubMed

37.

Mccluggage WG, Wilkinson N (2005) Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 47(3):231–247CrossRefPubMed

38.

Dolmans M-M, Luyckx V, Donnez J, Andersen CY, Greve T (2013) Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril 99(6):1514–1522CrossRefPubMed

39.

Durkin JR, Fine JL, Sam H, Pugliano-Mauro M, Ho J (2014) Imaging of Mohs micrographic surgery sections using full-field optical coherence tomography: a pilot study. Dermatol Surg 40(3):266–274CrossRefPubMed

40.

Rhiem K, Foth D, Wappenschmidt B, Gevensleben H, Büttner R, Ulrich U, Schmutzler RK (2011) Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers. Arch Gynecol Obstet 283:623–627CrossRefPubMed

41.

Kotzsch M, Bernt K, Friedrich K et al (2010) Prognostic relevance of tumour cell-associated uPAR expression in invasive ductal breast carcinoma. Histopathology 57(3):461–471CrossRefPubMed

42.

Van Dam GM, Themelis G, Crane LMA et al (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med 17(10):1315–1319CrossRefPubMed

43.

Andresen V, Alexander S, Heupel W-M, Hirschberg M, Hoffman RM, Friedl P (2009) Infrared multiphoton microscopy: subcellular-resolved deep tissue imaging. Curr Opin Biotechnol 20(1):54–62CrossRefPubMed

44.

Cahalan MD, Parker I, Wei SH, Miller MJ (2002) Two-photon tissue imaging: seeing the immune system in a fresh light. Nat Rev Immunol 2(11):872–880CrossRefPubMedPubMedCentral

45.

Themelis G, Harlaar NJ, Kelder W et al (2011) Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent. Ann Surg Oncol 18(12):3506–3513CrossRefPubMed

46.

Federa FMWV. Code for proper secondary use of human tissue in the Netherlands 2002. http://www.federa.org/codes-conduct

Title: Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue
Authors: Inge T. A. Peters
Carina G. J. M. Hilders
Cornelis F. M. Sier
Alexander L. Vahrmeijer
Vincent T. H. B. M. Smit
J. Baptist Trimbos
Peter J. K. Kuppen
Publication date: 01-08-2016
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 2/2016
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-016-4036-7

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2016

Adhesions and endometriosis: challenges in subfertility management

Q fever and pregnancy: experience from the Limoges Regional University Hospital

The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis

Reply on: Comment on: Hellmund et al. Rupture of renal artery aneurysm during late pregnancy: clinical features and diagnosis. Arch Gynecol Obstet. 2016;293:505–8

Comment on: Hellmund et al. Rupture of renal artery aneurysm during late pregnancy: clinical features and diagnosis. Arch Gynecol Obstet. 2016;293:505–8

MRI changes of pelvic floor and pubic bone observed in primiparous women after childbirth by normal vaginal delivery